DM
OLMA icon

Deerfield Management’s Olema Pharmaceuticals OLMA Stock Holding History

Deerfield Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-33,296
Closed -$398K – 323
2024
Q3 		$398K Buy
33,296
+1,891
+6% +$24.2K 0.01% 329
2024
Q2 		$340K Buy
+31,405
New +$341K 0.01% 321
2021
Q4 		– Sell
-271,191
Closed -$7.47M – 138
2021
Q3 		$7.47M Hold
271,191
– – 0.15% 102
2021
Q2 		$7.59M Hold
271,191
– – 0.13% 120
2021
Q1 		$9M Sell
271,191
-425,000
-61% -$18.2M 0.19% 105
2020
Q4 		$33.5M Buy
+696,191
New +$32.6M 0.66% 45

Other funds holding OLMA

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LMC
Lightspeed Management Company Menlo Park, California $988M AUM 7.5% 1-Year Est. Return

Deerfield Management's OLMA Position: Q4 2024 in Review

Deerfield Management sold out of Olema Pharmaceuticals (OLMA) in Q4 2024, closing a stake of 33,296 shares — an estimated $398K sold.

Deerfield Management first reported a position in OLMA in Q4 2020 and held it in 6 quarters. The position peaked at $33.5M in Q4 2020. 156 funds tracked by Wall St. Rank hold OLMA as of Q4 2024.

  • Deerfield Management reported no remaining Olema Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Deerfield Management sold 33,296 Olema Pharmaceuticals shares in Q4 2024, an estimated $398K.
  • Deerfield Management first reported a position in Olema Pharmaceuticals in Q4 2020 and held it in 6 quarters.
  • Deerfield Management's Olema Pharmaceuticals position peaked at $33.5M in Q4 2020.
  • 156 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q4 2024.

Based on Deerfield Management's 13F filing for Q4 2024, filed 14 Feb 2025.